1.Risk factors for hemorrhagic cystitis in children with β-thalassemia major after allogeneic hematopoietic stem cell transplantation.
Xiao-Ling CHEN ; Xiao-Juan LUO ; Ke CAO ; Tao HUANG ; Yuan-Gui LUO ; Chun-Lan YANG ; Yun-Sheng CHEN
Chinese Journal of Contemporary Pediatrics 2023;25(10):1046-1051
		                        		
		                        			OBJECTIVES:
		                        			To explore the risk factors for hemorrhagic cystitis (HC) in children with β-thalassemia major (TM) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT).
		                        		
		                        			METHODS:
		                        			A retrospective analysis was conducted on clinical data of 247 children with TM who underwent allo-HSCT at Shenzhen Children's Hospital from January 2021 to November 2022. The children were divided into an HC group (91 cases) and a non-HC group (156 cases) based on whether HC occurred after operation. Multivariable logistic regression analysis was used to explore the risk factors for HC, and the receiver operating characteristic curve was used to analyze the predictive efficacy of related factors for HC.
		                        		
		                        			RESULTS:
		                        			Among the 247 TM patients who underwent allo-HSCT, the incidence of HC was 36.8% (91/247). Univariate analysis showed age, incompatible blood types between donors and recipients, occurrence of acute graft-versus-host disease (aGVHD), positive urine BK virus deoxyribonucleic acid (BKV-DNA), and ≥2 viral infections were associated with the development of HC after allo-HSCT (P<0.05). Multivariable analysis revealed that incompatible blood types between donors and recipients (OR=3.171, 95%CI: 1.538-6.539), occurrence of aGVHD (OR=2.581, 95%CI: 1.125-5.918), and positive urine BKV-DNA (OR=21.878, 95%CI: 9.633-49.687) were independent risk factors for HC in children with TM who underwent allo-HSCT. The receiver operating characteristic curve analysis showed that positive urine BKV-DNA alone or in combination with two other risk factors (occurrence of aGVHD, incompatible blood types between donors and recipients) had a certain accuracy in predicting the development of HC after allo-HSCT (area under the curve >0.8, P<0.05).
		                        		
		                        			CONCLUSIONS
		                        			Incompatible blood types between donors and recipients, occurrence of aGVHD, and positive urine BKV-DNA are risk factors for HC after allo-HSCT in children with TM. Regular monitoring of urine BKV-DNA has a positive significance for early diagnosis and treatment of HC.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			beta-Thalassemia/therapy*
		                        			;
		                        		
		                        			Cystitis/epidemiology*
		                        			;
		                        		
		                        			Hematopoietic Stem Cell Transplantation/adverse effects*
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Hemorrhage/etiology*
		                        			;
		                        		
		                        			Graft vs Host Disease/complications*
		                        			;
		                        		
		                        			DNA
		                        			;
		                        		
		                        			Polyomavirus Infections/epidemiology*
		                        			
		                        		
		                        	
2.Sequencing and analysis of John Cunningham polyomavirus DNA from acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy.
Cai-Qin HU ; Jun-Wei SU ; Meng-Yan WANG ; Yong-Zheng GUO ; Li-Jun XU ; Ran TAO ; Yi-Rui XIE ; Ying HUANG ; Biao ZHU
Chinese Medical Journal 2020;133(23):2887-2889
3.Characteristics of BK polymavirus infection in kidney transplant recipients.
Yi ZHOU ; Leiyu YAO ; Zhe YU ; Naiqian CUI ; Fangxiang FU ; Yuedian YE ; Wenfeng DENG ; Jian XU ; Shaojie FU ; Ruming LIU ; Lixin YU ; Yun MIAO
Journal of Southern Medical University 2019;39(1):120-124
		                        		
		                        			OBJECTIVE:
		                        			To analyze the characteristics of BK polymavirus (BKV) infection and the optimal time window for intervention in kidney transplant recipients (KTRs).
		                        		
		                        			METHODS:
		                        			We retrospectively analyzed the clinical data and treatment regimens in 226 KTRs in our center between January, 2013 and January, 2018. Among the recipients, 157 had a urine BKV load ≥1.0×10 copy/mL after transplantation, and 69 had a urine BKV load below 1.0×10 copy/mL (control group).
		                        		
		                        			RESULTS:
		                        			Among the 157 KTRs, 60 (38.2%) recipients were positive for urine BKV, 66 (42.0%) had BKV viruria, and 31(19.7%) had BKV viremia. The incidence of positive urine occult blood was significantly higher in BKV-positive recipients than in the control group ( < 0.05). The change of urine BKV load was linearly related to that of Tacrolimus trough blood level (=0.351, < 0.05). In urine BKV positive group, the average estimated glomerular filtration rate (eGFR) was below the baseline level (60 mL·min·1.73 m) upon diagnosis of BKV infection reactivation, and recovered the normal level after intervention. In patients with BKV viruria and viremia, the average eGFR failed to return to the baseline level in spite of improvement of the renal function after intervention.
		                        		
		                        			CONCLUSIONS
		                        			Positive urine occult blood after transplantation may be associated with BKV infection reactivation in some of the KTRs. BKV infection is sensitive to changes of plasma concentration of immunosuppressive agents. Early intervention of BKV replication in KTRs with appropriate dose reduction for immunosuppression can help to control virus replication and stabilize the allograft function.
		                        		
		                        		
		                        		
		                        			BK Virus
		                        			;
		                        		
		                        			physiology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Kidney Transplantation
		                        			;
		                        		
		                        			Polyomavirus Infections
		                        			;
		                        		
		                        			virology
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Transplant Recipients
		                        			;
		                        		
		                        			Tumor Virus Infections
		                        			;
		                        		
		                        			virology
		                        			;
		                        		
		                        			Viral Load
		                        			;
		                        		
		                        			Virus Replication
		                        			
		                        		
		                        	
4.Prognosis of BK polyomavirus nephropathy: 10-year analysis of 133 renal transplant recipients at a single center.
Xu-Tao CHEN ; Shi-Cong YANG ; Jun LI ; Rong-Hai DENG ; Wen-Fang CHEN ; Jiang QIU ; Li-Zhong CHEN ; Chang-Xi WANG ; Gang HUANG
Chinese Medical Journal 2019;132(4):388-394
		                        		
		                        			BACKGROUND:
		                        			BK virus-associated nephropathy (BKVN) is an important cause of chronic allograft dysfunction. The objective of our study was to evaluate the prognosis of BKVN.
		                        		
		                        			METHODS:
		                        			We retrospectively reviewed the data of 133 renal transplant recipients with BKVN treated at the First Affiliated Hospital of Sun Yat-Sen University between July 2007 and July 2017. BK viral loads, graft function, and pathologic indexes were compared between initial diagnosis and last follow-up.
		                        		
		                        			RESULTS:
		                        			After a mean follow-up period of 14.4 (range, 0.3-109.6) months after diagnosis of BKVN, BK viruria, and BK viremia become negative in 19.5% and 90.2% of patients, respectively. The mean estimated glomerular filtration rate (eGFR) at last follow-up was lower than at diagnosis of BKVN (18.3 ± 9.2 vs. 32.8 ± 20.6 mL·min·1.73 m, t = 7.426, P < 0.001). Eight (6.0%) patients developed acute rejection after reducing immunosuppression. At last follow-up, the eGFR was significantly lower in patients with subsequent rejection than those without (21.6 ± 9.8 vs. 33.5 ± 20.9 mL·min·1.73 m, t = 3.034, P = 0.011). In 65 repeat biopsies, SV40-T antigen staining remained positive in 40 patients and became negative in the other 20 patients. The eGFR (42.6 ± 14.3 vs. 26.5 ± 12.3 mL·min·1.73 m), urine viral loads (median, 1.3 × 10vs. 1.4 × 10 copies/mL), and plasma viral load (median, 0 vs. 0 copies/mL) were all significantly lower in patients with negative SV40-T antigen staining than those with persistent BK involvement (all, P < 0.05). Five (3.8%) recipients lost their graft at diagnosis of BKVN, and 13 (9.8%) lost their graft during the follow-up period. The 1-, 3-, and 5-year graft survival rates after diagnosis of BKVN were 99.2%, 90.7%, and 85.7%, respectively. Higher pathologic stage correlated with lower allograft survival rate (χ = 6.341, P = 0.042).
		                        		
		                        			CONCLUSION
		                        			Secondary rejection and persistent histologic infection in BKVN lead to poor prognosis.
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			BK Virus
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Glomerular Filtration Rate
		                        			;
		                        		
		                        			Graft Rejection
		                        			;
		                        		
		                        			Graft Survival
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Kidney Diseases
		                        			;
		                        		
		                        			complications
		                        			;
		                        		
		                        			Kidney Transplantation
		                        			;
		                        		
		                        			adverse effects
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Polyomavirus Infections
		                        			;
		                        		
		                        			complications
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Viral Load
		                        			;
		                        		
		                        			Viremia
		                        			;
		                        		
		                        			complications
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
5.High Seroprevalence and Index of Anti-John-Cunningham Virus Antibodies in Korean Patients with Multiple Sclerosis
Su Hyun KIM ; Yeseul KIM ; Ji Yun JUNG ; Na Young PARK ; Hyunmin JANG ; Jae Won HYUN ; Ho Jin KIM
Journal of Clinical Neurology 2019;15(4):454-460
		                        		
		                        			
		                        			BACKGROUND AND PURPOSE: The anti-John-Cunningham virus (JCV)-antibody serostatus and index are used in the risk stratification of progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS) patients treated with natalizumab. However, little information on these parameters is available for Asian countries. The purpose of this study was to determine the rate of seropositivity, index, and longitudinal index evolution in Korean patients with MS. METHODS: The antibody seroprevalence was analyzed in 355 samples from 187 patients with clinically isolated syndrome or MS using a second-generation, two-step, enzyme-linked immunosorbent assay. A 4-year longitudinal evaluation was applied to 66 patients. RESULTS: The overall antibody seroprevalence was 80% (n=149). Among antibody-positive patients, the index had a median value of 3.27 (interquartile range, 1.52–4.18), with 77% (n=114) and 56% (n=83) of patients having indices >1.5 and >3.0, respectively. The serostatus of 59 (89%) of the 66 patients did not change during the longitudinal analysis, while 3 (6%) of the 53 patients who were initially seropositive reverted to seronegativity, and 2 (15%) of the 13 patients who were initially seronegative converted to seropositivity. All patients with a baseline index >0.9 maintained seropositivity, and 92% of patients with a baseline index >1.5 maintained this index over 4 years. No patients developed PML (median disease duration, 8 years). CONCLUSIONS: The seroprevalence and index of anti-JCV antibodies in Korean patients with MS may be higher than those in Western countries.
		                        		
		                        		
		                        		
		                        			Antibodies
		                        			;
		                        		
		                        			Asia
		                        			;
		                        		
		                        			Asian Continental Ancestry Group
		                        			;
		                        		
		                        			Enzyme-Linked Immunosorbent Assay
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			JC Virus
		                        			;
		                        		
		                        			Leukoencephalopathy, Progressive Multifocal
		                        			;
		                        		
		                        			Multiple Sclerosis
		                        			;
		                        		
		                        			Natalizumab
		                        			;
		                        		
		                        			Seroepidemiologic Studies
		                        			
		                        		
		                        	
6.Clinical manifestations of BK virus infection in pediatric kidney transplant patients
Yiyoung KWON ; Jeong Yeon KIM ; Yeonhee LEE ; Heeyeon CHO
Korean Journal of Pediatrics 2019;62(11):422-427
		                        		
		                        			
		                        			BACKGROUND: Polyomavirus BK (BKV) infection is an important cause of graft loss in kidney transplant patients.PURPOSE: The purpose of this study was to evaluate clinical findings and risk factors for BKV in pediatric patients after kidney transplantation.METHODS: This retrospective single-center study included 31 pediatric kidney transplant recipients from January 2002 to December 2017. Two patients received 2 transplantations during the study period, and each transplant was analyzed independently. Total number of cases is 33 cases with 31 patients. BKV infection was confirmed from blood samples via periodic quantitative polymerase chain reaction.RESULTS: The mean age at kidney transplantation was 11.0±4.7 years, and the male-to-female ratio was 2.7:1. Three patients had a past medical history of high-dose chemotherapy and autologous stem-cell transplantation for solid tumors. Nine patients (27.3%) developed BKV infection. The median period from kidney transplantation to BKV detection in blood was 5.6 months. There was no statistically significant difference in estimated glomerular filtration rate between patients with and those without BKV infection. Among 9 patients with BKV viremia, 7 were treated by reducing their immunosuppressant dose, and BKV was cleared in 6 of these 7 patients. In the other 2 BKV-positive patients, viremia improved without immunosuppressant reduction.CONCLUSION: BKV infection is common in children with kidney transplantation and might not have affected short-term renal function in our patient sample due to early immunosuppressant reduction at the time of BKV detection.
		                        		
		                        		
		                        		
		                        			BK Virus
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Drug Therapy
		                        			;
		                        		
		                        			Glomerular Filtration Rate
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Kidney Transplantation
		                        			;
		                        		
		                        			Kidney
		                        			;
		                        		
		                        			Polymerase Chain Reaction
		                        			;
		                        		
		                        			Polyomavirus
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Transplant Recipients
		                        			;
		                        		
		                        			Transplants
		                        			;
		                        		
		                        			Viremia
		                        			
		                        		
		                        	
7.Monitoring BK virus infection in pediatric kidney transplant recipients
Korean Journal of Pediatrics 2019;62(11):414-415
		                        		
		                        			
		                        			No abstract available.
		                        		
		                        		
		                        		
		                        			BK Virus
		                        			;
		                        		
		                        			Kidney
		                        			;
		                        		
		                        			Transplant Recipients
		                        			
		                        		
		                        	
8.Research Progress on BK Virus Infection after Hematopoietic Stem Cell Transplantation--Review.
Journal of Experimental Hematology 2018;26(6):1868-1871
		                        		
		                        			
		                        			BK virus infection is one of the common complications after hematopoietic stem cell transplantation(HSCT), which is also one of the reasons of the hemorrhagic cystitis.In recent years, although there are more studies of the risk factors related with human BK virus infection after hematopoietic stem cell transplantation, the risk factors related with BKV-associated hemorrhagio cystitis(BKV-HC) remain to be elucidated. Diagnosis of BK virus infection is mainly based on quantitative PCR of blood or urine. An effective strategy for treatment of these patients is the adoptive transfer of T lymphocytes specific to virus-associated antigens. In this review, the progressis of diagnosis and treatment of BK virus infection after hematopoietic stem cell transplantation are briefly summarized.
		                        		
		                        		
		                        		
		                        			BK Virus
		                        			;
		                        		
		                        			Cystitis
		                        			;
		                        		
		                        			Hematopoietic Stem Cell Transplantation
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Polyomavirus Infections
		                        			;
		                        		
		                        			Tumor Virus Infections
		                        			
		                        		
		                        	
9.Systematic review of the published data on the worldwide prevalence of John Cunningham virus in patients with multiple sclerosis and neuromyelitis optica.
Sonia Patricia Castedo PAZ ; Luciana BRANCO ; Marina Alves de Camargo PEREIRA ; Caroline SPESSOTTO ; Yara Dadalti FRAGOSO
Epidemiology and Health 2018;40(1):e2018001-
		                        		
		                        			
		                        			OBJECTIVES: John Cunningham virus (JCV) is a polyoma virus that infects humans, mainly in childhood or adolescence, and presents no symptomatic manifestations. JCV can cause progressive multifocal leukoencephalopathy (PML) in immunosuppressed individuals, including those undergoing treatment for multiple sclerosis (MS) and neuromyelitis optica (NMO). PML is a severe and potentially fatal disease of the brain. The prevalence of JCV antibodies in human serum has been reported to be between 50.0 and 90.0%. The aim of the present study was to review worldwide data on populations of patients with MS and NMO in order to establish the rates of JCV seropositivity in these individuals. METHODS: The present review followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and used the following search terms: “JCV” OR “JC virus” AND “multiple sclerosis” OR “MS” OR “NMO” OR “neuromyelitis optica” AND “prevalence.” These terms were searched for both in smaller and in larger clusters of words. The databases searched included PubMed, MEDLINE, SciELO, LILACS, Google Scholar, and Embase. RESULTS: After the initial selection, 18 papers were included in the review. These articles reported the prevalence of JCV antibodies in the serum of patients with MS or NMO living in 26 countries. The systematic review identified data on 29,319 patients with MS/NMO and found that 57.1% of them (16,730 individuals) were seropositive for the anti-JCV antibody (range, 40.0 to 69.0%). CONCLUSIONS: The median worldwide prevalence of JCV among adults with MS or NMO was found to be 57.1%.
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Antibodies
		                        			;
		                        		
		                        			Brain
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			JC Virus*
		                        			;
		                        		
		                        			Leukoencephalopathy, Progressive Multifocal
		                        			;
		                        		
		                        			Multiple Sclerosis*
		                        			;
		                        		
		                        			Natalizumab
		                        			;
		                        		
		                        			Neuromyelitis Optica*
		                        			;
		                        		
		                        			Polyomavirus
		                        			;
		                        		
		                        			Prevalence*
		                        			
		                        		
		                        	
10.Progress on pathogenesis of progressive multifocal leukoence-phalopathy.
Journal of Zhejiang University. Medical sciences 2018;47(5):534-540
		                        		
		                        			
		                        			Progressive multifocal leukoencephalopathy (PML) is a rare and lethal central nervous demyelinating disease caused by JC polyomavirus (JCV), particularly in patients with impaired immune system. The variation of JCV plays an important role in the pathogenesis of PML, including the recombination of non-coding regulatory region (NCCR), which is closely related to binding sites of transcription factors and affect the level of gene transcription. Nucleotide mutations in VP1 region determine the antigenicity and receptor specificity of JCV, play an important role in cell adsorption, immune-mediation and pathogenicity. In addition, immune cells are also involved in the pathogenesis of PML. T lymphocytes can recognize virus antigens, clear JCV, which are directly related to the prognosis of PML. B lymphocytes can serve as latent sites of JCV, and participate in viral transmission, replication, and coordination of the expression of transcription factors. This paper summarizes the roles of JCV variation and immune cells in pathogenesis of PML.
		                        		
		                        		
		                        		
		                        			B-Lymphocytes
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			virology
		                        			;
		                        		
		                        			Capsid Proteins
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			JC Virus
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			Leukoencephalopathy, Progressive Multifocal
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			virology
		                        			;
		                        		
		                        			Mutation
		                        			;
		                        		
		                        			T-Lymphocytes
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			virology
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail